SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-235413
Filing Date
2023-09-14
Accepted
2023-09-14 17:27:30
Documents
12
Period of Report
2023-09-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d507768d8k.htm   iXBRL 8-K 25751
  Complete submission text file 0001193125-23-235413.txt   147630

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230914.xsd EX-101.SCH 2525
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230914_lab.xml EX-101.LAB 17944
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230914_pre.xml EX-101.PRE 11235
6 EXTRACTED XBRL INSTANCE DOCUMENT d507768d8k_htm.xml XML 3447
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 231255981
SIC: 2834 Pharmaceutical Preparations